Memorial Sloan Kettering Cancer Center
This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.
Inclusion Criteria: * Age 18 to 65 years * Undergoing ambulatory extended recover (AXR) mastectomy (bilateral or unilateral) at the Josie Robertson Surgical Center (JSRC) Exclusion Criteria: * None
Modification to the pre-operative order set to remove gabapentin